DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has inked a new deal to provide its full suite of integrated chronic-condition management solutions to a national employer; this new contract outlines Dario’s commitment to support employees living with diabetes, high blood pressure, and needs related to weight, musculoskeletal pain and behavioral health. The new agreement follows the company’s announcement of numerous new agreements to provide similar multi-chronic suite solutions, an indication of the demand for Dario’s powerful approach to chronic condition management. An estimated 40% of the contracts the company has entered into this year include more than one solution, the company reported. “We believe that Dario’s ability to address five of the most costly and common chronic conditions with one integrated approach is resonating in a market that is saturated with point solutions,” said DarioHealth president and general manager, North America, Rick Anderson in the press release. “We are excited to partner with this new client and provide their employees with more continuous and connected support to improve their overall health.”
To view the full press release, visit https://ibn.fm/m6I6Q
About DarioHealth Corp.
DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition platform. The company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. DRIO’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
